6-acetylmorphine detected in the absence of morphine in pain management patients

Therapeutic Drug Monitoring

Volumn 31, Issue 6, 2009, Pages 749-752

  Crews, Bridgit ^a   Mikel, Charles ^a   Latyshev, Sergey ^a   West, Robert ^a   West, Cameron ^a   Pesce, Amadeo ^a   Friel, Patrick ^b  

^a Millennium Laboratories   (United States)

^b Washington State Patrol   (United States)

Author keywords

6 Acetylmorphine; Cutoffs; Morphine; Pain patients; Urinary excretion

Indexed keywords

MORPHINE; MORPHINE 6 ACETATE;

ARTICLE; DRUG DETERMINATION; DRUG URINE LEVEL; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; PAIN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY;

ANALGESICS, OPIOID; ANALYTIC SAMPLE PREPARATION METHODS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLUCURONIDASE; HUMANS; HYDROLYSIS; MORPHINE; MORPHINE DERIVATIVES; PAIN; REFERENCE VALUES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY; UNITED STATES;

EID: 73849126333     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3181b9da04     Document Type: Article

References (9)

1. Moeller KE, Lee KC, Kissack JC. Urine drug screening: practical guide for clinicians. Mayo Clin Proc. 2008;83:66-76.
2. Paul BD, Shimomura ET, Smith ML. A practical approach to determine cutoff concentrations for opiate testing with simultaneous detection of codeine, morphine, and 6-acetylmorphine in urine. Clin Chem. 1999;45: 510-519.
3. Rook EJ, Huitema AD, van den Brink W, et al. Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature. Curr Clin Pharmacol. 2006;1:109-118.
4. Mandatory Guidelines and Proposed Revisions to Mandatory Guidelines for Federal Workplace Drug Testing Programs; Notices Section 2.4
5. Laboratory Analysis Procedures (f) (1) confirmatory drug test. Federal Register. Vol.69, No.71, Tuesday, Notices page 19659, April 13, 2004.
6. Beck O, Böttcher M. Paradoxical results in urine drug testing for 6-acetylmorphine and total opiates: implications for best analytical strategy. J Anal Toxicol. 2006;30:73-79.
7. Potter PM, Wadkins RM. Carboxylesterases-detoxifying enzymes and targets for drug therapy. Curr Med Chem. 2006;13:1045-1054.
8. Wheelock CE, Shan G, Ottea J. Overview of carboxylesterases and their role in the metabolism of insecticides. J Pesticides Sci. 2005;30:75-83.
9. Marsh S, Xiao M, Yu J, et al. Pharmacogenomic assessment of carboxylesterases 1 and 2. Genomics. 2004;84:661-668.